Sun Pharma�s ANDA for Azelastine Nasal Spray Gets FDA Nod
un Pharmaceuticals has revealed that its abbreviated new drug application for Azelastine HCL nasal spray has been approved by the US FDA.
un Pharmaceuticals has revealed that its abbreviated new drug application for Azelastine HCL nasal spray has been approved by the US FDA.
"This approval further strengthens the company's branded dermatology portfolio in the US. It expects XiminoTM extended-release capsules to be available for patients during the fourth quarter of 2015," said the Mumbai-based company.
Sun Pharma is the world's fifth largest specialty generic pharmaceutical company and India's top pharmaceutical firm. The company's consolidated revenues for 12 months ended March 2015 stood at around USD 4.5 billion, of which US contributed USD 2.2 billion.
Sun Pharma Announces Closure of Merger Deal With Ranbaxy
Sun Pharmaceutical Industries, India's largest pharma company, announced the closure of its merger with Ranbaxy Laboratories. This makes them world's fifth largest maker of generic drugs.
Sun Pharmaceutical Industries, India's largest pharma company, announced the closure of its merger with Ranbaxy Laboratories. This makes them world's fifth largest maker of generic drugs.
Leadership Award in Healthcare Industry to be Announced Soon
Micro Labs, Sun Pharma, Cipla & Glenmark, the top 4 major pharmaceutical companies in India have been nominated by Indian Affairs Business Leadership Awards 2012.
Micro Labs, Sun Pharma, Cipla & Glenmark, the top 4 major pharmaceutical companies in India have been nominated by Indian Affairs Business Leadership Awards 2012.
FDA Issues Recall of 200 Vials of Sun Pharma�s Chemo Drug
The US Food and Drug Administration has announced that it has recalled around 200 vials of a chemotherapy drug.
The US Food and Drug Administration has announced that it has recalled around 200 vials of a chemotherapy drug.
